172 filings
8-K
AGIO
Agios Pharmaceuticals Inc
2 May 24
Agios Reports Business Highlights and First Quarter 2024 Financial Results
7:01am
8-K
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
8-K
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
AGIO
Agios Pharmaceuticals Inc
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am
8-K
AGIO
Agios Pharmaceuticals Inc
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
8-K
cllq1m1
14 Jun 23
Departure of Directors or Certain Officers
4:05pm
8-K
ttqh000kn v6
25 May 23
Departure of Directors or Certain Officers
4:02pm
8-K
3vj7cpuly 1sb7qxqpwu
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
p04sn
19 Apr 23
Departure of Directors or Certain Officers
7:26am
8-K
1nmna7x11a66imgj a0
3 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
yce8nt1ssa
23 Feb 23
Agios Reports Fourth Quarter and Full Year 2022 Financial Results
7:02am
8-K
koy6sb
9 Jan 23
Regulation FD Disclosure
7:18am
8-K
ajbs3y fhdkd7fv
16 Dec 22
Departure of Directors or Certain Officers
4:02pm
8-K
xg3qot85x0x13o j323f
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
xpqfjmszx8zk7sqpy
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
3nmywt60y0nzn1 ryvjv
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
hpxz8ddw
7 Oct 22
Departure of Directors or Certain Officers
4:05pm
8-K
nrh xe6nuyi1s
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
h9jd2zps2wu
7 Sep 22
Departure of Directors or Certain Officers
7:03am
8-K
rf4nkbu
15 Aug 22
Departure of Directors or Certain Officers
4:22pm